A drastic superoxide-dependent oxidative stress is prerequisite for the down-regulation of IRP1: Insights from studies on SOD1-deficient mice and macrophages treated with paraquat

PLoS One. 2017 May 19;12(5):e0176800. doi: 10.1371/journal.pone.0176800. eCollection 2017.

Abstract

Iron regulatory protein 1 (IRP1) is a cytosolic bifunctional [4Fe-4S] protein which exhibits aconitase activity or binds iron responsive elements (IREs) in untranslated regions of specific mRNA encoding proteins involved in cellular iron metabolism. Superoxide radical (O2.-) converts IRP1 from a [4Fe-4S] aconitase to a [3Fe-4S] "null" form possessing neither aconitase nor trans-regulatory activity. Genetic ablation of superoxide dismutase 1 (SOD1), an antioxidant enzyme that acts to reduce O2.- concentration, revealed a new O2.--dependent regulation of IRP1 leading to the reduction of IRP1 protein level and in consequence to the diminution of IRP1 enzymatic and IRE-binding activities. Here, we attempted to establish whether developmental changes in SOD1 activity occurring in the mouse liver, impact IRP1 expression. We show no correlation between hepatic SOD1 activity and IRP1 protein level neither in pre- nor postnatal period probably because the magnitude of developmental fluctuations in SOD1 activity is relatively small. The comparison of SOD1 activity in regards to IRP1 protein level in the liver of threeSOD1 genotypes (Sod1+/+, Sod1+/- and Sod1-/-) demonstrates that only drastic SOD1 deficiency leads to the reduction of IRP1 protein level. Importantly, we found that in the liver of fetuses lacking SOD1, IRP1 is not down-regulated. To investigate O2.--dependent regulation of IRP1 in a cellular model, we exposed murine RAW 264.7 and bone marrow-derived macrophages to paraquat, widely used as a redox cycler to stimulate O2.-production in cells. We showed that IRP1 protein level as well as aconitase and IRE-binding activities are strongly reduced in macrophages treated with paraquat. The analysis of the expression of IRP1-target genes revealed the increase in L-ferritin protein level resulting from the enhanced transcriptional regulation of the LFt gene and diminished translational repression of L-ferritin mRNA by IRP1. We propose that O2.--dependent up-regulation of this cellular protectant in paraquat-treated macrophages may counterbalance iron-related toxic effects of O2.-.

MeSH terms

  • Animals
  • Apoferritins / genetics
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects*
  • Gene Expression Regulation / drug effects
  • Iron Regulatory Protein 1 / genetics
  • Iron Regulatory Protein 1 / metabolism*
  • Kidney / drug effects
  • Kidney / metabolism
  • Liver / drug effects
  • Liver / metabolism
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Macrophages / cytology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • Oxidative Stress / drug effects*
  • Paraquat / pharmacology*
  • RAW 264.7 Cells
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, LDL / deficiency
  • Receptors, LDL / metabolism
  • Superoxide Dismutase-1 / deficiency*
  • Superoxides / metabolism*
  • Tumor Suppressor Proteins / deficiency
  • Tumor Suppressor Proteins / metabolism

Substances

  • Low Density Lipoprotein Receptor-Related Protein-1
  • Lrp1 protein, mouse
  • RNA, Messenger
  • Receptors, LDL
  • Tumor Suppressor Proteins
  • Superoxides
  • Apoferritins
  • Superoxide Dismutase-1
  • Iron Regulatory Protein 1
  • Paraquat

Grants and funding

This work was supported by grant no. 2011/01/B/NZ3/00632 from the National Center of Science (Narodowe Centrum Nauki) (PL).